Priority Date: 21.12.11 (US 201161578589P)

SUBSTITUTED PIPERIDINES AS HDM2 INHIBITORS

  • Application ID: EP12860596
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
7 offices
Technology Company
no operation time available
4 offices
Technology Company
no operation time available
4 offices
Technology Company
no operation time available
4 offices
Technology Company
no operation time available
4 offices
Technology Company
no operation time available
7 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Merck Sharp & Dohme Corporation, Merck Sharp & Dohme Ltd., and Merck & Co. Inc. are specialized in A61. Merck Sharp & Dohme Ltd., Merck Sharp & Dohme Corporation, Merck & Co. Inc., Merck Sharp & Dohme Corporation, Merck & Co. Inc., Merck Sharp & Dohme Ltd. is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 21.12.2011 - Priority Date (US 201161578589P)
  • 27.06.2013 - Publication A1 (WO2013096150)
  • 29.10.2014 - Publication A1 (EP2793890)
  • 07.09.2016 - Publication B1 (EP2793890)

IPC Classification